...
首页> 外文期刊>The American Journal of Medicine >Creatinine Clearance Is Not Equal to Glomerular Filtration Rate and Cockcroft-Gault Equation Is Not Equal to CKD-EPI Collaboration Equation
【24h】

Creatinine Clearance Is Not Equal to Glomerular Filtration Rate and Cockcroft-Gault Equation Is Not Equal to CKD-EPI Collaboration Equation

机译:肌酐清除率不等于肾小球滤过率,Cockcroft-Gault方程不等于CKD-EPI协作方程

获取原文
获取原文并翻译 | 示例
           

摘要

Direct oral anticoagulants (DOACs) may require dose reduction or avoidance when glomerular filtration rate is low. However, glomerular filtration rate is not usually measured in routine clinical practice. Rather, equations that incorporate different variables use serum creatinine to estimate either creatinine clearance in mL/min or glomerular filtration rate in mL/min/1.73 m(2). The Cockcroft-Gault equation estimates creatinine clearance and incorporates weight into the equation. By contrast, the Modification of Diet in Renal Disease and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations estimate glomerular filtration rate and incorporate ethnicity but not weight. As a result, an individual patient may have very different renal function estimates, depending on the equation used. We now highlight these differences and discuss the impact on routine clinical care for anticoagulation to prevent embolization in atrial fibrillation. Pivotal DOAC clinical trials used creatinine clearance as a criterion for patient enrollment, and dose adjustment and Federal Drug Administration recommendations are based on creatinine clearance. However, clinical biochemistry laboratories provide CKD-EPI glomerular filtration rate estimations, resulting in discrepancies between clinical trial and routine use of the drugs. (C) 2016 Elsevier Inc. All rights reserved.
机译:当肾小球滤过率低时,直接口服抗凝剂(DOAC)可能需要减少剂量或避免使用。但是,肾小球滤过率通常不在常规临床实践中测量。相反,包含不同变量的方程式使用血清肌酐来估计肌酐清除率(mL / min)或肾小球滤过率(mL / min / 1.73 m(2))。 Cockcroft-Gault方程估算肌酐清除率并将重量合并到该方程中。相比之下,肾脏疾病和慢性肾脏病流行病学协作(CKD-EPI)方程中的饮食调整估计肾小球滤过率,并包含种族但不包括体重。结果,根据所使用的公式,单个患者的肾功能估计值可能会非常不同。现在,我们着重强调这些差异,并讨论抗凝对预防心房颤动栓塞对常规临床护理的影响。关键的DOAC临床试验使用肌酐清除率作为患者入组的标准,并且剂量调整和联邦药物管理局的建议均基于肌酐清除率。但是,临床生化实验室提供CKD-EPI肾小球滤过率估算值,导致临床试验与常规使用药物之间存在差异。 (C)2016 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号